Cost-effectiveness analysis of cisplatin plus etoposide and carboplatin plus paclitaxel in a phase III randomized trial for non-small cell lung cancer

Aim: Carboplatin plus paclitaxel is a more costly chemotherapy regimen than cisplatin plus etoposide; however there have been reports of higher efficacy and less toxicity of this regimen. Thus, this study aimed to assess the cost-effectiveness of these two chemotherapy regimens in advanced non-small...

Full description

Saved in:
Bibliographic Details
Main Authors: Sumitra Thongprasert, Unchalee Permsuwan, Chidchanok Ruengorn, Chaiyut Charoentum, Busyamas Chewaskulyong
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=83355175819&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/50141
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Be the first to leave a comment!
You must be logged in first